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Summary 
Positive selection of T cells is a complex developmental process generating long-lived, function- 
ally  mature  CD4+CD8 -  and  CD4-CD8 +  cells  from  short-lived,  immature  CD4+CD8 + 
precursors. The process is initiated in the thymus by interaction of the o~ TCR with molecules 
encoded by the MHC, occurs without cell division, and involves rescue from programmed cell 
death  (PCD),  as well as induction  of differentiation  and maturation  of selected presursors.  It 
is unclear whether development of small,  positively selected CD4 +  CD8 § thymocytes (charac- 
terized by up-regulated  levels of TCR and CD69 molecules) depends on further  interactions 
with MHC molecules and, if so, whether such interactions are required for survival, for matura- 
tion, or for both. The involvement of the TCR and/or CD4/CD8 coreceptors in transmitting 
additional signals is also unknown. We have examined these questions by analyzing survival and 
differentiation of early (CD4 +  CD8 +  TCR  hi) and later (CD4- CD8 +  TCR.  hi) postselection stages 
of thymocytes from normal  and bcl-2 transgenic mice expressing transgenic,  class I MHC-re- 
stricted TCR, upon intrathymic  transfer into recipients that lacked ligands either for both the 
TCR and CD8 coreceptor, or for the TCR only. The results provide direct evidence that induc- 
tion of differentiation of CD4+CD8 + thymocytes by recognition of MHC molecules does not 
rescue them from PCD and is insufficient  to activate the entire maturation program. Both processes 
require continual engagement of the TCR by positively selecting MHC molecules that, at least 
in the case of class  I MHC-restricted  CD4-CD8 + T  cells,  cannot be substituted by the en- 
gagement  of coreceptor alone. 
A 
cording  to  the  concept  of  programmed  cell  death 
(PCD) 1 (reviewed in reference  1),  survival and devel- 
opment of cells depend on suppression of apoptosis, which 
can be viewed as a biochemical "time bomb" that will kill 
the cell at a predetermined hour unless its clock is set back 
by environmental  factors.  This  view poses  an  interesting 
problem  concerning  the  relationship  between  signals  that 
rescue cells from PCD and those that induce differentiation 
and/or maturation at various developmental stages of different 
cell lineages.  Here we are concerned with  this question in 
relation  to the role of the a/3 TCR. and CD8 coreceptor- 
mediated interactions  with class I MHC molecules during 
T cell development. These interactions are believed to be criti- 
cally involved in the generation of the majority of long lived 
(>8 wk), mature CD4-CD8 + (CD8 +) T cells recognizing 
antigenic peptides presented by class I MHC molecules from 
short lived (3.5 d), small,  resting CD4+CD8 + thymocytes. 
1 Abbreviations used in this paper: APC, allophycocyanin; fl2m, fl2-micro- 
globulin; HSA, heat-stable antigen; PCD, programmed cell death. 
This  process and  the parallel  process of generation  of the 
majority of CD4 § CDS-  (CD4 +)  T  cells,  which  involves 
TCR, and CD4 coreceptor-mediated interactions with class 
II MHC molecules, are called positive selection (for a recent 
review,  see reference 2). 
Positive  selection  of mature  T  cells  from  CD4§  + 
precursors does not require cell division (3) and is accompa- 
nied by a number of changes in addition to down-modulation 
of CD4 or CD8 molecules. They include the up-regulation 
of cell surface expression of the TCR (4, 5),  an increase  of 
Bcl-2  protein  levels  (6,  7),  termination  of  activity  of 
recombination-activating genes (RAG-1 and RAG-2) (8, 9), 
transient expression of an early activation marker CD69 (10, 
11), and down-regulation of heat-stable antigen  (HSA) ex- 
pression  (11, 12). 
The role of TCK- and/or CD4/CD8 coreceptor-mediated 
interactions  in the rescue from PCD  and in the induction 
of differentiation of CD4+CD8 + thymocytes is unclear and 
has only recently begun to be analyzed in more detail. It was 
shown that Bcl-2-mediated suppression of apoptosis in the 
absence of TCR-ligand interaction does not result in any of 
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13),  indicating  that  TCR-mediated  signals  are  required  to 
initiate the differentiation of CD4 +  CD8 +  TCR  l~ thymocytes 
and that interactions with MHC molecules via CD4/CD8 
coreceptors  alone  are  unable  to  do  so,  even when  CD4 + 
CD8+TCK t~ thymocytes are rescued from PCD by the bd-2 
transgene.  However, the requirement  for interactions  with 
positively selecting MHC-peptide complexes in suppressing 
apoptosis and their role in promoting further differentiation 
of selected CD4 +  CD8 +  TCR.  hi thymocytes that have already 
received  a  TCR-mediated  signal  have  not  been  directly 
analyzed. 
Several recent studies provided indirect evidence suggesting 
that  the  initial  TCR-ligand  interaction  resulting  in  up- 
regulation of cell surface TCR levels and down-regulation 
of CD4 or CD8 coreceptors may not be sufficient to rescue 
immature thymocytes from PCD and that more than a single 
interaction  of developing T  cells  with  positively selecting 
MHC-peptide  complexes  may be necessary for end-stage 
differentiation (11, 14-19). For example, detection of thymo- 
cytes  arrested  at  the  CD4+CD81~  hi  stage  of 
differentiation in class II MHC-deficient mice (14, 20) and 
an  analogous  population  of  CD41~ 
thymocytes in class I MHC-deficient mice (15,  16) was in- 
terpreted as indicating that CD4 § CD8 + thymocytes engage 
positively selecting MHC-peptide complexes twice en route 
to becoming end-stage CD4 § and CD8 + thymocytes: the 
first engagement would provoke random down-modulation 
of either CD4 or CD8 molecules; the second (requiring par- 
ticipation of the appropriate coreceptor) would permit end- 
stage differentiation  (14). The successful differentiation  of func- 
tionally mature CD8 + (endogenous CD4-) T  cells in class 
I MHC-deficient  mice expressing the CD4  transgene  (15, 
21) and CD4 + T  cells in class II MHC-deficient  mice ex- 
pressing the CD8 transgene  (22) seems to support this in- 
terpretation,  but  whether  involvement  of  the  TCR  in 
delivering the second signal was required or whether core- 
ceptor-mediated interactions with MHC molecules without 
participation  of the TCR were suf~cient remains  an  open 
question. This question becomes relevant and important  in 
view of the results of a recent study (18),  in which it was 
found  that  CD4-CD8+TCRhiHSA hi  thymocytes  in  re- 
arrangement-deficient  mice expressing only a single species 
of transgenic TCR, restricted by class II MHC molecules, 
could not fully mature if selected in class I MHC-deficient 
mice  even  though  the  TCR  showed  no  detectable  cross- 
reactivity with class I MHC molecules. This result was in- 
terpreted as consistent with the notion that  single interac- 
tion with positively selecting MHC-peptide complexes is not 
sufficient  to induce end-stage differentiation  of developing 
thymocytes, thus implying that a second interaction (in this 
case of CD8 with class I MFIC molecules not involving coen- 
gagement  of the  TCR)  was probably involved. 
All of these observations stern from the analysis of thymo- 
cytes expressing "mismatched" combinations of the TCR with 
CD4/CD8 coreceptors, and one cannot be sure whether the 
apparent failure to rescue these cells from PCD and the postu- 
lated requirement  for multiple TCR-mediated  interactions 
apply  as  well  to  CD4+CD8 +  thymocytes,  which  down- 
modulated the "matched" coreceptor as a result of the first 
encounter of the TCR with positively selecting ligand. Thus, 
the following specific questions concerning the role of TCR- 
and CD4/CD8 coreceptor-mediated interactions in intrathy- 
mic T cell development remain unanswered: (a) Is the devel- 
opment of small CD4+CD8+TCR hi thymocytes that were 
activated by the initial TCR-mediated signal dependent on 
or independent from further interactions  of the TCR with 
its ligand? (b) Is the development dependent on interactions 
involving coreceptors alone? (c) If the development of selected 
CD4 + CD8 +  TCR  hi thymocytes is dependent on further in- 
teractions with positively selecting ligands, are they required 
for survival or for maturation,  or for both? 
Here we directly examine these questions by analyzing sur- 
vival and differentiation of isolated early and late postselec- 
tion  stages  of  thymocytes  expressing  transgenic,  class  I 
MHC-restricted TCR upon intrathymic  transfer into reci- 
pients that lack ligands either for both the TCR and CD8 
coreceptor,  or for the TCR only. 
Materials  and Methods 
Mice.  C57BL/6 (B6), BALB/c, and (B6 x BALB/c)F1 (BDF1) 
mice were obtained from the animal colony of the Basel Institute 
for Immunology (Basel, Switzerland). AKR/J mice were purchased 
from the Jackson Laboratory (Bar Harbor,  ME). The H-2  b and 
H-2  d TCRc~B transgenic mice expressing receptor specific for the 
HY antigen  in the context  of H-2D  b molecules were described 
previously (23, 24) and were bred at the Basel Institute for Immu- 
nology. The H-2  b/b and H-2  a/d bcb2/TCR bitransgenic mice were 
produced by serial crosses of the transgenic E/~-bcl-2-25 strain (24), 
kindly provided by Dr. S. Cory (Walter and Eliza Hall Institute 
of Medical Research, Royal Melbourne  Hospital,  Victoria, Aus- 
tralia),  with  the H-2  b/b or H-2  aid anti-HY  TCR~3  transgenic 
mice. The bone marrow irradiation chimeras were produced by in- 
travenous injection of T cell depleted (anti-Thyl.2  + C treated, 45 
rain, 37~  bone marrow cells (3  x  106 per mouse) from H-2  d/d 
bcl-2/TCR bitransgenic donors into lethally irradiated (950 fads) 
H-2  b/d BDF1 mice. The chimeric mice served as donors of thymo- 
cytes 8-10 wk after irradiation and bone marrow reconstitution. 
All other mice were used in experiments at the age of 6-10 wk. 
Antibodies and Other Reagents.  The following  conjugates  of 
mAbs  were used: T3.70-FITC  (anti-HY/D b transgenic  TCR) 
(23), anti-CD4-PE (Becton Dickinson,  Heidelberg, FRG), anti- 
CD8-biotin  (Becton  Dickinson),  anti-CDS-Red-613  (GIBCO 
BRL,  Gaithersburg,  MD),  M1/69-biotin  (anti-HSA)  (25), and 
anti-Thyl.2-FITC  (Becton Dickinson). FITC-conjugated Fab' frag- 
ments of mAb T3.70 were kindly provided by Jorg Kirberg (Basel 
Institute of Immunology). Streptavidin-allophycocyanin (APC) con- 
jugate was purchased from Southern Biotechnology Associates  (Bir- 
mingham, AL), and streptavidin-Tri-Color conjugate was purchased 
from Caltag Laboratories (San Francisco, CA). 
Sorting of Thymocytes.  The  small CD4+CD8+T3.70 hi  and 
small CD4-CDS+T3.70 hi cells (Fig.  1) were sorted  at  4~  by 
FACStar-Plus (Becton Dickinson) flow cytometer as described (11, 
26) from the populations of thymocytes, which were triple stained 
with  anti-CD4-PE,  anti-CD8-Red-613,  and Fab' fragments  of 
T3.70-FITC mAbs. Fab fragments of mAb T3.70  were used to 
avoid activation of sorted cells. In some experiments anti-CD8- 
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613-conjugated anti-CD8 mAb. 
Intrathymic Transfer  and Fluorometric  Analysis of the Fate of  Injected 
Cells.  Sorted  populations of cells were injected into both thymic 
lobes of nonirradiated, anesthetized recipients (1-3 x  105 cells per 
lobe in 10-/xl volumes) with the aid of a B-D Micro-Fine IV sy- 
ringe mounted on a TRIDAK Stepper (Indicon Inc., Brookfield 
Center, CT). 
2-4 d later, the mice were sacrificed, and their thymuses were 
removed and analyzed  for the presence of the injected  cells as follows. 
Thymocyte suspension from the whole thymus was prepared in 
PBS supplemented  with 2% FCS, and total cell number was counted 
before the first wash. After washing and removing clumps of ag- 
gregated  dead cells, the  remaining  cells were stained with 
T3.70-FITC, anti-CD4-PE, anti-CD8-Red-613, and M1/69-biotin 
plus streptavidin-APC or with T3.70-FITC, anti-CD4-PE,  anti- 
CDS-biotin plus streptavidin-Tri-Color  and analyzed on FACStar- 
Plus flow cytometer. In some experiments thymocyte suspension 
was divided into two: one half were stained with T3.70-FITC, 
anti-CD4-PE, and anti-CD8-biotin plus streptavidin-Tri-Color;  the 
other half were stained with T3.70-FITC and M1/69-biotin  plus 
streptavidin-Tri-Color; alternatively, one half were stained with 
T3.70-FITC,  and the other half were stained with anti-Thyl.2- 
FITC. Stained  cells were analyzed  on FACScan  flow cytometer.  5-10 
million thymocytes  were analyzed  by cytofluorometer,  but acquisi- 
tion gates were set such as to exclude the great majority of FITC- 
negative cells from further analysis. The live cells were then gated 
from acquired FITC-positive cells on the basis of forward and side 
scatter profile to reveal the population of T3.70 § or Thyl.2  + cells. 
Analysis of the size of recovered T3.70  hi cells revealed that they 
consisted exclusively  of small cells. The analysis  of CD4, CD8, and 
HSA expression was performed on gated live T3.70  hi cells. 
The total number of recovered T3.70  h~ cells was calculated as 
follows: (total no. of thymocytes) (no. of T3.70  h~ cells in analyzed 
sample)/(no, of cells analyzed). The percent recovery of T3.70  hi 
cells was calculated as follows: (total no. of recovered T3.70  ~i cells) 
(100)/(no. of injected T3.70  h~ cells). 
Results 
Experimental Approach.  To obtain insight into the role of 
interactions with positively selecting ligands in rescue from 
PCD and in differentiation of developing T cells, we followed 
the fate of purified populations of small TCR  hi thymocytes 
(CD4+CD8 §  or  CD4-CD8§  see  Fig.  1)  expressing  a 
transgenic,  class  I  MHC  (H-2Db)-restricted,  male  (HY) 
antigen-specific  TCR (T3.70 §  (23,  24),  after intrathymic 
transfer into three groups of recipients:  (a) normal syngeneic 
(H-2  b) female mice expressing the positively selecting ligand 
with which both the TCR and CD8 coreceptor could in- 
teract;  (b)  syngeneic (H-2b),  class I  MHC-deficient  (~2- 
microglobulin  -/-  [32m -/- ] female mice lacking ligands for 
both the TCR and CD8 coreceptor; and (c) normal aUogeneic 
(H-2  d or H-2  k) female mice lacking the ligand for the TCR 
but  not  for  CD4/CD8  coreceptors.  The  injected  small 
CD4+CD8+T3.70 hi  thymocytes represented  cells  that  al- 
ready received at least one positive selection signal because, 
as previously demonstrated (11, 27), they express elevated levels 
of CD69 molecules and can be found in mice expressing posi- 
tively selecting H-2D  b molecules and not in mice lacking 
these molecules.  We reasoned that analysis of the survival 
and differentiation of purified CD4 +  CD8 +  TCR  hi thymo- 
cytes from TCR transgenic or bcl-2/TCR double transgenic 
donors, injected intrathymically into these mice, should not 
only establish  whether further interactions with positively 
selecting ligands are necessary, but should also distinguish 
the developmental requirement for engagement of the TCR 
from requirement for engagement of coreceptor molecules 
alone (if, as suggested by experiments of Kirberg et al. (18), 
the latter type of interactions play a role in development of 
immature T  cells). 
We showed previously (28) that the differentiation of small 
CD4 +  CD8 +  TCR  1~ thymocytes into mature CD4- CD8 + 
TCR  hi cells via the CD4 +  CD8 +  TCR  hi stage can proceed in 
the thymus of allogeneic,  H-2-incompatible recipients  ex- 
pressing selecting class I MHC molecules. This indicated that 
an alloresponse  against intrathymically injected cells either 
did not take place or was insufficient to interfere with posi- 
tive selection  and that anti-CD4, anti-CD8, and anti-TCR 
antibodies used to purify the injected cells (see Materials and 
Methods) did not adversely affect their ability to differen- 
tiate. For these and other reasons that will be discussed later, 
we believe that it is unlikely that the experimental condi- 
tions of our study could unphysiologicaUy  interfere with the 
normal development of injected cells; nevertheless, one should 
be aware of the possible impact of steroid-mediated stress and 
generally low cell recoveries in this type of experiments. 
Rescue of Immature Thymocytes from PCD Depends on Con- 
tinual Engagement of the TCR  by Positively Selecting Ligand. 
highly purified, small CD4 +  CD8 §  T3.70  hi thymocytes from 
H-2  b TCR transgenic females were injected intrathymically 
into B6 (H-2  b) and into class I MHC-deficient 32m-/-  (H- 
2  b) as well as into BALB/c (H-2 d) or AKR/J (H-2 k) female 
mice.  After 2 or 4 d,  the thymuses of recipient mice were 
analyzed for the presence of injected T3.70 hs cells, and their 
CD4/CD8 phenotype was determined. As shown in Fig. 2 
and in  Table  1,  a  substantial proportion  of injected cells 
(3-10%) could be recovered from B6 (D  b+) recipients,  and 
>90% of recovered cells were CD4- CD8 +. In contrast, al- 
ready after 2 d, no or very few (<0.5%) T3.70 hi cells could 
be recovered from D b-  (i.e.,/32m-/-, BALB/c, or AKR/J) 
recipients.  It is not clear whether the few cells that scored 
as  T3.70 hi  were  of the  donor  origin  or  represented  the 
"background" of nonspecifically  stained cells of the recip- 
ient, but in contrast to truly T3.70 ~ cells recovered from the 
B6 recipient,  the great majority of them were CD4 +  CD8 § 
Contrary to  CD4 +  CD8 +T3.70  hi thymocytes, comparable 
numbers  of the injected CD4-CD8 + T3.70  hi thymocytes 
could  be  recovered  from  B6  as  well  as  from  B2m -/-, 
BALB/c, and AKR/J mice (Fig. 3 and Table 1). These results 
suggested that  the  CD4+CD8 §  cells,  in  contrast  to  the 
CD4-CD8 § cells, did not survive in the absence of TCR 
engagement by positively selecting ligand and that possible 
interactions with MHC molecules mediated by coreceptor 
molecules alone were unable to rescue CD4 + CD8 +  TCR  hi 
cells  from  PCD.  However,  it  should  be  noted  that 
CD4-CD8 § ceils recovered from H-2D  b- thymuses injected 
1977  Kisielow  and Miazek I H-2b  TCR-Tg 
I THYMOCYTES 
I H-2d  bcl-2/TCR-Tg  ~  H-2d/b chimera ] 
UNSORTED 
/ 
￿9  ~do  ,~e  g6e  Sbd~ebo 
SORTED 
small  CD4+8+T3.70hi 
CO8 
~~  i*'~ 
FSC 
T3.70 
small  CD4-8+T3.70hi 
ee  s60  ~60  ~e~e 
UNSORTED  SORTED 
small  CD4+8+T3.70hi 
CD8 
E  eo  e  ~e  eee  le e  "  '  .........  1 'c,  .......  '  "  ' "  'e  e  zoo  4ee  6co  eoo  e  e  .= 
FSO 
/ 
i  o .........  t  ..............  ie,  .......  t~q  1  o..  1~1  1r  .2.  i~  )  i~ 
T3.70 
Figure  1.  Kepresentative  phenotypes  of purified cell populations  used in intrathymic  transfer  experiments.  Small CD4+CD8+T3.70 hi and small 
CD4-CD8 +  T3.70 hi calls were sorted from total populations  of thymocytes of the TCR transgenic H-2  b (or bcl-2/TCR bitransgenic H-2b; not shown) 
and of bcl-2/TCg bitransgenic  H-2  d -~ H-2  d/b female mice using the indicated  gates as described in Materials and Methods.  The purity of sorted 
populations  ranged from 99.3 to 99.8% for TCR transgenic and bcl-2/TCR bitransgenic  H-2  b mice and from 98.2 to 99.1%  for bcl-2/TCR bitrans- 
genic H-2  d -~ H-2  d/b chimeric mice. Note that all sorted  and reanalyzed populations  (immature  CD4 +  CD8 + and mature CD4-CD8 *) exhibited 
somewhat reduced intensity of staining with all flourochrome-coupled  mAbs (anti-CD4,  anti-CD8, and T3.70)  as compared with the original staining 
indicated by gates in unsorted  populations.  This reflects the general loss of fluorescence accompanying the sorting procedure rather than contamination 
with cells expressing lower levels of markers in the original population.  The possibility that sorted CD4 + CD8 +  TCR.  hi cells contained few unselected 
CD+CD8 + cells that nonspecifically up-regulated  TCR level in vitro (34) cannot  be excluded, but it is unlikely in view of the fact that  sorting was 
performed  at 4~  (see Materials and Methods). 
with  CD4-CD8 + T3.70 hi  cells  expressed  reduced  TCR. 
levels as compared with cells recovered from thymuses of B6 
(D  b+) recipients (Fig.  3).  Thus, one could argue that the 
inability to detect T3.70 hi cells in H-2D b-  recipients after 
injection of CD4 § CD8 +TCR  hi thymocytes is due to down- 
modulation of the TCR rather than to the absence  of in- 
jected cells. To test this possibility,  we have used anti-Thyl.2 
antibody in addition to mAb T3.70, to search for the pres- 
ence of injected CD4+CD8 § thymocytes in AKR/J (Thyl.1) 
recipients.  The results shown in Fig. 4 demonstrate that in 
contrast  to  the recipients  of CD4-CD8+TCR h~ cells,  no 
Thyl.2 §  cells  could  be  recovered  from  the  recipient  of 
CD4 +  CD8 +  TCR  hi thymocytes, thus indicating that the in- 
ability to detect T3.70 hi cells results from their true absence 
and is not due to down-modulation of the TCR. We con- 
clude from these results that recognition of positively selecting 
ligand by  CD4§  1~ thymocytes leading to  up- 
regulation of TCRs level does not rescue them from PCD 
and that  survival  of selected  CD4 ~  CD8 +TCR  hi cells,  in 
contrast to CD4-CD8+TCR hi thymocytes, is dependent on 
continual interaction of the TCR with positively selecting 
ligand, which at least in the case of class I MHC- restricted 
CD8 § T  cells cannot be substituted by interactions medi- 
ated by coreceptors  alone. 
Not Only Rescue  from PCD but Also Differentiation and Matu- 
ration of Thymocytes Depend on Continual Engagement of the 
TCR  by Positively Selecting Ligand.  The results previously 
described  do not answer the question of whether multiple 
engagements of the TCR by positively selecting ligand during 
the  development  of mature  CD8 §  T  cells  from  CD4 § 
CD8 +  TCR  hi thymocytes are needed only to suppress apop- 
tosis or are also needed to induce end-stage differentiation 
of these cells. To answer this question and to discriminate 
between the possible  requirement for TCR-mediated and 
TCR-independent coreceptor-mediated induction of end-stage 
differentiation, we performed similar intrathymic transfer ex- 
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Figure 2.  TCR transgenic CD4 § 
CD8+T3.70 hi  thymocytes  cannot 
be recovered from H-2Db-deficient 
recipients.  Small  CD4+CD8+ 
T3.70 hi  thymocytes  (EXP.  1: 
3  x  105, purity  99.6%;  EXP. 2: 
2  x  105, purity 99.3%) from H-2  b 
TCR. transgenic  female mice were 
injected intrathymically into the in- 
dicated female recipients.  2 or 4 d 
later,  the recipient  thymuses were 
analyzed for the presence of T3.70  hi 
cells (gate R2), and their CD4/CD4 
phenotypes were determined as de- 
scribed in Materials and Methods. 
Numbers in quadrants indicate per- 
centages.  For percent  recovery of 
T3.70 hi cells, see Table 1. 
Table  1.  Recovery of Intrathymically Injected Cells (Summary of All Experiments) 
Donor/phenotype  of 
injected cells  Recipient 
Recovery (%  _+  SD)* 
Day 2  Day 4  Positive/total 
H-2 b TCR  Tg/  B6 
CD4 +  8 +  T3.70 hi  ~2m-/- 
BALB/c 
AKR/J 
H-2 b TCR  Tg/  B6 
CD4- CD8 +  T3.70 hi  32m-/- 
BALB/c 
AKR/J 
H-2 b bcl-2/TCR Tg/  B6 
CD4 § CD8 § T3.70 hi  32m -/- 
BALB/c 
H-2  d bcl-2/TCR  Tg/  B6 
CD4 §  § T3.70 hi  BALB/c 
5.0  (2.4-7.4)  (n  =  3) 
<0.5  (n  =  1) 
<0.3  (n  =  3) 
<0.1  (n  =  1) 
10.0  (n  =  1) 
6.8  (n  =  1) 
11.1  (7.4-14.8)(n  =  2) 
8.0  (n  =  1) 
ND 
ND 
ND 
ND 
ND 
7.1  _+  2.7  (n  =  7) 
<0.2  (n  =  3) 
<0.5  (n  =  6) 
<0.2  (n  =  2) 
13.9  (11.4-16.4)  (n  =  2) 
4.3  _+  2.9  (n  =  4) 
7.5  _+  2.1  (n  =  4) 
6.3  (3.2-9.4)(n  =  2) 
15.7  _+  5.6  (n  =  4) 
21.7  (17.1-26.3)  (n  =  2) 
17.4  _+  6.2  (n  =  4) 
10.8  (8.2-13.0)  (n  =  3) 
8.2  (4.4-12.4)  (n  =  3) 
10/10 
0/4 
0/9 
0/3 
3/3 
5/5 
6/6 
3/3 
4/4 
2/2 
4/4 
3/3 
3/3 
" When n  =  3,  the range is given in parentheses. 
ND,  not done; Tg,  transgenic. 
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Figure 3.  TCR transgenic CD4-CD8 + T3.70 hi thymocytes can be re- 
covered  from  H-2Db-deficient  recipients.  Small  CD4-CD8*T3.70 hi 
thymocytes (3  x  10  s, purity 99.5%) from H-2b TCR transgenic female 
mice were injected intrathymically into the indicated female recipients. 
4 d later,  the recipient thymuses were analyzed for the presence of T3.70 hi 
cells  as  described  in  Materials  and  Methods.  For  percent  recovery of 
T3.70 h~ cells,  see Table  I. Broken lines mark the expression level (mean 
fluorescence) of TCR on cells recovered from the B6 recipient expressing 
positively selecting ligand for T3.70+  TCR.  Note the reduced expres- 
sion level of T3.70 § TCR on cells recovered from fl2m -/-  and BALB/c 
recipients  that  lack ligand for T3.70+  TCR. 
periments using CD4 § CD8 +  T3.70 hi thymocytes from the 
TCR and bcl-2 double transgenic mice in which apoptosis 
of thymocytes is strongly suppressed  (reference 13, and our 
own unpublished results). As shown in Fig. 5,  differentia- 
tion of the double transgenic CD4 §  hi thymo- 
cytes in fl2m -/-  and in BALB/c recipients is strongly in- 
hibited  as compared with  differentiation occurring in B6 
recipients.  Although a substantial  proportion of T3.70  hi cells 
RECIPIENT 
[ ~,2m-/-  (H-2b) ] 
I BALB/c (H-2d) ] 
RECOVERY AND  PHENOTYPE OF T3.70  hI  CELLS 
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T3.70 
i :: 
i| 
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Figure  5.  Inhibition of differentiation of H-2  b bcl-2/TCR bitransgenic 
CD4 +  CD8 +  T3.70 hi  thymocytes  in  H-2Db-deficient  recipients.  Small 
CD4+CD8+T3:70 hi thymocytes (3  x  10  s, purity 99.4%) from H-2  b bcl- 
2/TCR bitransgenic female mice were injected intrathymicaUy into the 
indicated female recipients. 4 d later, the recipient thymuses were analyzed 
for the presence of T3.70  hi cells, and their CD4/CD8 phenotypes and level 
of liSA expression were determined as described in Materials and Methods. 
Broken vertical lines mark the highest expression level (mean fluorescence) 
of TCR and HSA molecules.  Note that  ceils  recovered from recipients 
lacking ]igand for T3.70+  TCR express  reduced levels of TCR and high 
levels of HSA. For comparison,  the expression level of HSA in the total 
population of recipient thymocytes is indicated by a dotted line. Numbers 
in quadrants  indicate percentages.  For percent recovery of T3.70 hi cells, 
see Table 1. 
recovered  from  fl2m -/-  and  BALB/c  recipients  down- 
modulated CD4 coreceptor, they did not (in contrast to cells 
recovered from B6 recipients) down-modulate HSA mole- 
cules.  These results strongly suggested that not only sup- 
pression of apoptosis but also end-stage differentiation of class 
I MHC-restricted CD8 + T cells is dependent on continual 
engagement of the TCR,  which cannot be substituted by 
engagement of coreceptors alone. However, the fact that some 
of the double  transgenic CD4 +CD8 +T3.70 hi  thymocytes 
RECIPIENT 
AKFt/J 
(H-2k, Thyl.1) 
RECOVERY  OF T3.70 hi  AND THY1.2 + CELLS  CELLS'NJECTEO  l 
I  sm.,,  i  L CD4+8+T3"70h i 
I  small 
C04-8+T3.70hi 
R2 
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￿9  . ! ~.  ~  .m17r7 
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Figure  4.  Small CD4+CD8+T3.70 hi thymocytes in con- 
trast  to small CD4-CD8+T3.70 hi thymocytes do not  sur- 
vive in the absence of continual engagement of the TCR by 
positively selecting ligand.  Small CD4* CD8 § T3.70 hi and 
small CD4-CD8+T3.70 hi thymocytes from H-2  b, Thy.l.2 
TCR transgenic female mice (5  x  l0  s, purity >99%) were 
injected intrathymically into AKR (H-2  k, Thyl.1) recipients. 
4 d later,  the recipient thymuses were analyzed for the pres- 
ence  of T3.70 hi  as  well  as  Thyl.2+  calls  as  described  in 
Materials  and  Methods.  Note  the absence  of T3.70 hi and 
Thyl.2 + cells in recipients injected with small CD4 § CD8 § 
T3.70 hi cells.  This experiment was repeated twice with the 
same results. 
1980  Role of T  Cell Receptor during  Positive Selection down-modulated CD4 coreceptor in recipients lacking posi- 
tively selecting ligands could indicate that  the rescue from 
PCD is sufficient to allow at least  some differentiation  of 
CD4+CD8 +  thymocytes  activated  by  the  initial  TCR- 
mediated interaction, which in the absence of further TCR 
engagement is simply slowed down. Alternatively, since the 
injected  cells  themselves  expressed  H-2D  b molecules,  the 
down-modulation of CD4 coreceptors by some CD4 +  CD8 + 
T3.70 hi thymocytes in 32m-/-  and BALB/c recipients could 
result from interactions between intratbymically transferred 
thymocytes. To test these alternatives  and to exclude formally 
the possibility that  MHC incompatibility between donors 
and recipients has influenced our results, we performed ex- 
periments  in  which  differentiation  of small  H-2  d bcl-2/ 
TCR  bitransgenic  CD4+CD8+T3.70 hi  thymocytes  posi- 
tively selected in thymuses of BDF1 (H-2  b/d) mice was com- 
pared after intrathymic transfer into BALB/c and B6 recipients. 
The results shown in Fig. 6 indicate that the great majority 
(86-91%)  of  H-2  d  (i.e.,  H-2D  b-)  bitransgenic  T3.70 ha 
thymocytes  recovered  from  BALB/c  (H-2  d)  recipients  re- 
mained  CD4+CD8 §  whereas  the  majority  (64-83%)  of 
T3.70 hi cells recovered  from B6 thymus were CD4-CD8 § 
These  results  suggest  that  down-modulation  of the  CD4 
coreceptor  on  H-2D  b+  double  transgenic  CD4+CD8 § 
T3.70 hi  thymocytes  injected  into  H-D b-  thymus  is  due 
largely to interactions  among injected thymocytes. Such TCR- 
mediated interactions with class I MHC molecules that can 
occur between thymocytes could explain the results of our 
RECOVERY  AND  CD41CD8  PHENOTYPE  OF 
T3.70hI  CELLS 
RECIPIENT 
B6 (H-2b)[ 
BALB/c (H-2d)[ 
R~ 
t----I 
T3.70 
O 
91.e 
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Figure  6.  Differentiation  of CD4 +  CD8 +  T3.70 hi thymocytes  rescued 
from PCD requires continual engagement of the TCR by positively selecting 
ligand. Small CD4+CD8+T3.70 "i thymocytes (3  x  10  s, purity 98.5%) 
from bcl-2/TCK bitransgenic  H-2  d ~  H-2  d/b female mice were injected 
intrathymically into the indicated female recipients. 4 d later, the recipient 
thymuses  were  analyzed  for  the  presence  of T3.70  hi  cells, and  their 
CD4/CD4 phenotypes  were determined  as described  in Materials  and 
Methods.  Broken lines mark the highest  expression level (mean fluores- 
cence) of TCK. Numbers in quadrants indicate percentages. In two other 
experiments  the percentages of cells in the upper (CD4 +  CD8 +) and the 
lower (CD4-CDS+)  right quadrants  recovered from B6 and  BALB/c 
recipients were 14/83 versus 90/9 and 24/75 versus 86/13,  respectively. 
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earlier in vitro experiments  (27) as well as those of others 
(17),  in which it was shown that CD4+CD8 + TCR  hi cells 
were able to complete their differentiation to CD4-CD8 + 
T cells in culture in the apparent absence of thymic stromal 
elements. In the present experiments, somewhat less efficient 
differentiation  of  H-2  a  bitransgenic  CD4 +CD8 +T3.70 hi 
thymocytes than of H-2  b bitransgenic  CD4 +  CD8 +  T3.70 hi 
thymocytes in B6 (H-2  b) recipients (compare Figs.  5 and 6) 
may also reflect  the fact  that  interactions  among  injected 
thymocytes contribute to the efficiency of differentiation. The 
small proportion  of H-2  a double transgenic  CD4-CD8 + 
T3.70  hi  thymocytes that  can be  still  detected  in  BALB/c 
recipients could at least in part represent contaminants of ma- 
ture thymocytes originally present in purified population of 
CD4 +CD8+T3.70 hi cells. 
Thus, we conclude from these experiments that rescue from 
PCD and differentiation of mature class I MHC-restricted 
CD8 + T  cells from positively selected CD4 +CD8 +TCR  hi 
thymocytes depend on continual interaction of the TCR with 
positively selecting ligand. 
Discussion 
8 yr ago it was postulated that positive selection of T cells 
initiated by TCR-MHC interaction involves rescue from PCD 
(29).  Although  this notion received experimental  support, 
the stage of development at which survival of positively selected 
cells becomes independent  of TCR-MHC  interactions  re- 
mained undetermined.  Moreover, the relationship between 
differentiation and suppression of apoptosis during positive 
selection  as  well  as  the  role  of TCR  and/or  CD4/CD8 
coreceptors in transmitting signals responsible for these two 
effects  has  also remained  unclear. 
In the present study we have approached these questions 
by analyzing the fate of CD4+CD8 + precursor thymocytes 
expressing class I MHC-restricted TCR after intrathymic in- 
jection into mice deficient in ligands for both the TCR and 
the CD8 coreceptor or for the TCR only. Using TCR trans- 
genic or TCR/bcl-2 double transgenic mice as donors of posi- 
tively selected CD4 +  CD8 § TCR  hi cells,  we could examine 
the requirement for the continual engagement of the TCK 
versus  the  requirement  for  the  continual  engagement  of 
coreceptors alone in rescuing from PCD and in promoting 
differentiation.  We showed that  within  2  d  after transfer, 
CD4+CDS+T3.70 hi  thymocytes of TCR  transgenic  mice 
vanished from the recipient thymus without generating any 
intrathymic  progeny unless their TCR molecules were al- 
lowed to interact  further  with  positively selecting H-2D  b 
molecules. In the latter case, within 2-4 d the CD4 +  CD8 + 
T3.70hiHSA hi  thymocytes  down-regulated  expression  of 
CD4  and  HSA  molecules  and  became  the  CD4-CD8 § 
T3.70hiHSN ~ thymocytes that were independent  of further 
interactions with positively selecting ligands, at least for their 
short term (>4 d) survival.  These results are compatible with 
conclusions drawn from DNA labeling studies (3) that the 
lifespan of CD4 § CD8 § thymocytes is the same irrespective 
of whether or not they undergo positive selection: selected ceils change their phenotype at the end of the 3.5-d period, 
whereas unselected cells die by apoptosis. Our present results 
complement these conclusions by indicating that the induc- 
tion of differentiation by recognition of positively selecting 
ligand does not rescue CD4 +  CD8 § thymocytes from PCD 
and that suppression of apoptosis is the end result of the posi- 
tive selection, which requires continual interaction  of the TCR 
with  positively selecting ligand. 
The requirement  of CD4 +  CD8 § TCR  hi cells,  positively 
selected by class I MHC-peptide complexes, for further in- 
teraction  with these molecules cannot be fulfilled by providing 
the ligand for the CD8 coreceptor only. This conclusion is 
supported by the observation that in contrast to the aUogeneic 
recipients expressing the ligand for T3.70 + TCR (28),  the 
allogeneic recipients  lacking the ligand for T3.70 + TCR but 
not for the CD8 coreceptor were unable to support develop- 
ment  of  intrathymically  transferred,  positively  selected 
CD4 +  CD8 +T3.70 hi thymocytes. Thus,  our present results 
provide the first direct evidence that positive selection of ma- 
ture class I MHC-restricted CD8 + T cells is dependent on 
continual engagement  of the TCR. by its ligand and that it 
cannot be substituted by interactions mediated by coreceptors 
alone not only during initiation (7,  13) but also at the subse- 
quent  stages of positive selection of these cells. 
Our observation that mature CD8 § thymocytes survive 
for at least 4 d in the thymic environment lacking positively 
selecting ligands but down-modulate the expression level of 
the TCR may suggest that mature T cells can also be depen- 
dent on interactions with selfMHC molecules; not for their 
survival,  but for maintaining  the surface expression of the 
TCR at  the appropriate  level. 
Whether  the requirement  for intrathymic  expression of 
class I MHC molecules during maturation  of the CD8 § T 
cells expressing class II MHC-restricted TCR, reported by 
Kirberg et al.  (18),  reflects  the need for CD8-class I MHC 
interaction not involving the TCR. remains to be established. 
This possibility could be directly analyzed by an approach 
similar  to  that  used in  the  current  study,  namely,  by in- 
trathymic transfer of the early postselection stages of thymo- 
cytes into recipients lacking the ligand for the TCR but not 
for CD8 molecules. 
Our currrent experiments have not addressed the question 
of whether development of class I MHC-restricted  CD8 + 
T cells from CD4 +  CD8 +  TCR  hi thymocytes requires coen- 
gagement of the TCR with CD8 coreceptor. The coreceptor 
function of CD8 molecules during positive selection of class 
I MHC-restricted  CD8 § T  cells was demonstrated  previ- 
ously (30, 31),  but in these studies, it was not determined 
whether coengagement of CD8 with the TCR by the same 
MHC molecule is required at all stages of positive selection. 
The requirement  for involvement of CD4 and CD8 mole- 
cules during later stages of positive selection was documented 
in  cases  in  which  maturation  of thymocytes  that  down- 
regulates the "wrong"  coreceptor was induced by a trans- 
gene encoding the "correct" coreceptor (15, 21, 32), but the 
question of whether coengagement of the TCR was also re- 
quired was not studied. The importance ofcoreceptors during 
initiation of positive selection was demonstrated in another 
recent study (22) which showed that not only maturation, 
but  also  generation  of  cells  with  "mismatched"  CD4 § 
CD8 l~ phenotype in class II MHC-deficient mice required 
the presence of CD8 molecules. However, none of the afore- 
mentioned studies allow one to conclude that further devel- 
opment  of the positively selected CD4 § CD8 +TCR hi thy- 
mocytes  is  dependent  on  coreceptor  function  involving 
coengagement of the TCR.  This question and that  of the 
importance of coengagement of the TCR with CD8 corecep- 
tor for survival and differentiation of developing thymocytes 
can be approached by transfer experiments  similar to those 
reported here using recipients bearing mutation in the CD8- 
binding or3 domain of class I MHC molecules; these were 
unavailable  to us.  Thus,  the elucidation  of the role of the 
coreceptors in promoting development of positively selected 
CD4 +  CD8 +  TCR hi thymocytes requires further  study. 
In the current study we have shown that sustained interac- 
tion of the TCR with its ligand is required not only for sur- 
vival,  but also for full maturation  of developing T  cells be- 
cause,  unlike in IL-3-dependent multipotent  hematopoietic 
stem cell line (33), bcl-2-mediated suppression of apoptosis 
in  unselected  CD4+CDS+TCR.I~  13)  and  in  positively 
selected  CD4+CD8+TCR hi  thymocytes  does  not  lead  to 
further differentiation  in the absence of additional  signals trans- 
mitted by the TCR.. 
In conclusion, our results indicate that positive selection 
cannot  be  regarded  as  a  process  that  rescues  immature 
CD4 § CD8 § thymocytes with potentially "useful" receptors 
from PCD and simultaneously or subsequently triggers  or 
enables expression of intrinsically  determined maturation pro- 
gram.  Rather,  it can be seen  as a process that  induces the 
differentiation  program  in  potentially  "useful"  immature 
thymocytes by continuous TCR-mediated signaling and then 
rescues from PCD only those cells that successfully completed 
the  whole differentiation  program.  The  latter  strategy  of 
selecting useful T  cells  seems more prudent. 
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